IT Versione italiana

up-dating events » Fighting pain: appropriate drugs and neuropathic pain


New treatments for neuropathic pain according to the recommendations governing the use of FANS

The N°. 66 recommendation of AIFA (Italian Agency - Pharmaceutical Association) warns against the risk cardiac and cerebral patients may undergo when taking high dosage of NSAID. Patients affected by neuropatic pain now have a new treatment: a self injectable low dosage (25,50 75mg) of Diclofenac. The symposium, sponsored by IBSA on occasion of the 67° SIIARTI Congress, sees the participation of key experts, of different fields and formation, focusing on their experiences and future developments.




presentations

speakers' interviews



Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK